|Company Name||Last Price||%
|Dr Reddys Labs||2413.15||-1.52||2545.00||1764.00||41,047.62|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
Ind-Swift Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 113.30 crore.The company has reported a standalone sales of Rs 237.93 crore and a Net Loss of Rs 8.57 crore for the quarter ended Sep 2013.
The company management includes S R Mehta - Chairman, N R Munjal - Vice Chairman & Mng.Director, Himanshu Jain - Joint Managing Director, Rishav Mehta - Executive Director, V R Mehta - Director, G Munjal - Director, K M S Nambiar - Director, T S Bhattacharya - Director, J K Kakkar - Director, Pradeep Kumar - Director, R K Ummat - Director, Satyendra Vikram Singh - Nominee Director.
It is listed on the BSE with a BSE Code of 532305 and the NSE with an NSE Code of INDSWFTLAB.
Its Registered office is at SCO 850, Shivalik Enclave,,NAC, Manimajra Chandigarh,Chandigarh - 160101.
Their Registrars are Alankit Assignment Ltd.